Sofinnova Investments, Inc. Axsome Therapeutics, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.23 Billion
- Q4 2024
A detailed history of Sofinnova Investments, Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 100,000 shares of AXSM stock, worth $13.8 Million. This represents 0.69% of its overall portfolio holdings.
Number of Shares
100,000
Previous 150,000
33.33%
Holding current value
$13.8 Million
Previous $13.5 Million
37.22%
% of portfolio
0.69%
Previous 1.27%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
36.3MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$558 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$538 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$455 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$202 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$191 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.91B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...